Overview


According to FutureWise analysis the market for Breast Reconstruction in 2023 is US$ 0.6 billion, and is expected to reach US$ 0.81 billion by 2031 at a CAGR of 3.70%.

A breast reconstruction operation is performed to rebuild a breast after a mastectomy or lumpectomy surgery. Mastectomy surgery involves the removal of the entire breast, while lumpectomy surgery involves the removal of a portion of the breast. After surgery, a woman may choose to undergo breast reconstruction immediately, or she may choose to delay the procedure until a later time. These procedures are typically performed as part of the treatment plan for women undergoing surgery to remove breast cancer or a precancerous lesion.  Breast reconstruction is an important option for many women who have undergone breast surgery, as it can help to restore a woman's sense of femininity, body image, and self-esteem.

Breast reconstruction can be performed using a variety of techniques, including implant-based reconstruction, autologous tissue reconstruction, or a combination of both. Implant-based reconstruction involves the use of saline or silicone breast implants to create a new breast mound. Autologous tissue reconstruction involves using a woman's own tissue, typically from the abdomen, back, or thighs, to create a new breast mound. In some cases, a combination of implant-based and autologous tissue reconstruction may be used to achieve the desired outcome.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Breast Reconstruction Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Breast Reconstruction Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Integra Lifesciences
  • RTI Surgical Holdings
  • Mentor Worldwide LLC
  • Establishment Labs S.A.
  • Silimed
  • Allergan Aesthetics Inc.
  • GC Aesthetics
  • POLYTECH Health & Aesthetics
  • Ideal Implant Incorporated
  • Sebbin
  • Sientra

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Breast Reconstruction Market:

  • In January 2022, The US FDA authorized a new MENTOR® MemoryGel BOOST™ Breast implant from Mentor Worldwide LLC.

Various factors, including the increasing prevalence of breast cancer, rising awareness about breast reconstruction procedures, and technological advancements in breast implants and tissue expanders drive the global breast reconstruction market. The increasing prevalence of breast cancer is a major driver of the breast reconstruction market. Breast cancer is the most widespread type of cancer among women across the world, and the incidence of the disease is increasing. As a result, the number of women undergoing mastectomies or lumpectomies is also increasing, driving the demand for breast reconstruction procedures. Moreover, the rising awareness about breast reconstruction procedures drives the market. Breast reconstruction can help restore a woman's sense of femininity, self-confidence, and body image after a mastectomy or lumpectomy. The increasing awareness of the benefits of breast reconstruction is expected to drive the demand for the procedure in the coming years. Technological advancements in breast implants and tissue expanders are also driving the market. The development of new materials, such as silicone and saline implants, and the introduction of new techniques, such as autologous tissue transfer, have improved the safety, efficacy, and aesthetic outcomes of breast reconstruction procedures. The increasing adoption of these technologies is expected to fuel market growth in the years to come.

However, the breast reconstruction market also faces some challenges, such as the high cost of the procedure, the lack of reimbursement policies in some countries, and the risk of complications and side effects. The high cost of the procedure may limit access to breast reconstruction for some women, particularly those without insurance coverage. The lack of reimbursement policies in some countries may also limit the demand for the procedure.

By Product

  • Breast Implants
    • By Type
      • Silicone Breast Implants
      • Saline Breast Implants
    • By Shape
      • Round Shape
      • Anatomical Shape
    • Tissue Expander
      • Saline Expander
      • Air Tissue Expander
    • Acellular Dermal Matrix

By Procedure

  • Immediate
  • Delayed
  • Revision

By Type

  • Unilateral
  • Bilateral

By End User

  • Hospitals
  • Cosmetology Clinics and Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Due to the rising frequency of breast cancer, rising breast augmentation operations, and developed healthcare infrastructure, North America is anticipated to lead the breast reconstruction market throughout the projection period. This region's market is anticipated to expand due to the increasing number of product approvals. For instance, in March 2022, Sientra Inc. was given approval by Health Canada to commercialise its range of smooth surface silicone gel breast implants in Canada. In addition, the market for breast reconstruction in North America is also anticipated to expand because of the increased attention that industry participants are paying to this region. Additionally, based on product; breast implants held the highest market share in 2022.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  •  To provide with an exhaustive analysis on the Breast Reconstruction Market By Product, By Procedure, By Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Breast Reconstruction Market Variables, Trends and Scope
    •         1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Breast Reconstruction Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Breast Reconstruction Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Breast Reconstruction Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Breast Implants
         1.1. By Type
          1.1.1. Silicone Implants
          1.1.2. Saline Implants
         1.2. By Shape
          1.2.1. Round Implants
          1.2.2. Anatomical Implants
         1.3. Tissue Expander
          1.3.1. Saline Expander
          1.3.2. Air Tissue Expander
         1.4. Acellular Dermal Matrix

  • 8.   Breast Reconstruction Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immediate
        2. Delayed
        3. Revision

  • 9.   Breast Reconstruction Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Unilateral
        2. Bilateral

  • 10.   Breast Reconstruction Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Cosmetology Clinics and Ambulatory Surgical Centers

  • 11.   North America Breast Reconstruction Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Breast Reconstruction Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Breast Reconstruction Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Breast Reconstruction Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Breast Reconstruction Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Integra Lifesciences
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. RTI Surgical Holdings
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Mentor Worldwide LLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Establishment Labs S.A.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Silimed
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Allergan Aesthetics Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. GC Aesthetics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. POLYTECH Health & Aesthetics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ideal Implant Incorporated
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sebbin
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sientra
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients